Incretin mimetics as emerging treatments for type 2 diabetes

Joy SV, Rodgers PT, Scates AC 

OBJECTIVE: To review the physiology, pharmacology, and clinical efficacy of glucagon-like peptide (GLP-1) and the incretin mimetics exenatide and liraglutide in clinical studies.  (more) 

 

 


Joy SV, Rodgers PT, Scates AC. Incretin mimetics as emerging treatments for type 2 diabetes. Ann Pharmacother. 2005;39:110-118. 

Last Modified: 2/4/2013